openPR Logo
Press release

Circulating Tumor Cells Market Growth Fueled by Rising Cancer Incidence | Major Companies are QIAGEN, Fluxion Biosciences, Inc., Greiner Bio One International GmbH

08-14-2025 04:00 PM CET | Health & Medicine

Press release from: DataM Intelligence 4market Research LLP

Circulating Tumor Cells Market

Circulating Tumor Cells Market

The Global Circulating Tumor Cells Market reached US$ 11.80 billion in 2023 and is expected to reach US$ 26.61 billion by 2031, growing at a CAGR of 11.1% during the forecast period 2024-2031.

Circulating Tumor Cells Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/circulating-tumor-cells-market?nrk

Circulating tumor cells (CTCs) are cancer cells that break away from the primary tumor and enter the bloodstream, playing a critical role in metastasis. Detecting and analyzing CTCs helps in early cancer diagnosis, treatment monitoring, and understanding disease progression. Liquid biopsy techniques enable non-invasive CTC detection, providing an alternative to traditional tissue biopsies. The CTC market is growing due to advancements in cancer research and personalized oncology. Emerging technologies aim to enhance CTC capture and analysis for improved clinical applications.

Market Dynamics:

The increasing number of cancer cases is one of the significant key factors that help the market to grow during the forecast period. For instance, according to the National Center for Health Statistics. In 2023, 1,958,310 new cancer cases and 609,820 cancer deaths are projected to occur in the United States. Cancer incidence increased for prostate cancer by 3% annually from 2014 through 2019 after two decades of decline, translating to an additional 99,000 new cases; otherwise, however, incidence trends were more favourable in men compared to women. As cancer prevalence rises, there is a growing need for effective cancer diagnostics and monitoring tools along with CTC-based assays and technologies. This presents a significant opportunity for companies operating in the market to develop innovative products and solutions that enable the detection, enumeration, and molecular characterization of CTCs.

Industry Development:

On January 3, 2025, researchers from the German Cancer Research Center (DKFZ) successfully cultivated stable tumor organoids from circulating tumor cells (CTCs) in breast cancer patients. This breakthrough allows for the study of therapy resistance and the development of targeted treatments. The organoids can be used to identify specific molecular pathways that support cancer cell survival, potentially leading to innovative therapeutic strategies tailored to individual patients. This method represents a significant advancement in understanding metastatic processes and could pave the way for personalized medicine in breast cancer treatment.

Key Players:

Thermo Fisher Scientific Inc, QIAGEN, Fluxion Biosciences, Inc., Greiner Bio One International GmbH, Ikonisys Inc., BioFluidica, Biolidics Limited, Creativ MicroTech Inc., Menarini Silicon Biosystems, StemCell Technologies.

Growth Forecast Projected:

The Global Circulating Tumor Cells Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Circulating Tumor Cells Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=circulating-tumor-cells-market

Market Segmentation:

By Product Type: Devices, Kits & Assays, Consumables

By Technology: CTC Detection and Enrichment Method, CTC Direct Detection Method, SERS, Microscopy, Others, CTC Analysis

By Application: Liquid Biopsy, Research, Clinical, Others

By Specimen: Blood, Bone Marrow, Others

By End User: Hospitals, Clinics, Diagnostic Centers, Others

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Benefits of the Report:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.

➡ Top-down and bottom-up approach for regional analysis

➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.

➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/circulating-tumor-cells-market

People Also Ask:

➠ What is the global sales, production, consumption, import, and export value of the Circulating Tumor Cells market?

➠ Who are the leading manufacturers in the global Circulating Tumor Cells industry? What is their operational status in terms of capacity, production, sales, pricing, costs, gross margin, and revenue?

➠ What opportunities and challenges do vendors in the global Circulating Tumor Cells industry face?

➠ Which applications, end-users, or product types are expected to see growth? What is the market share for each type and application?

➠ What are the key factors and limitations affecting the growth of the Circulating Tumor Cells market?

➠ What are the various sales, marketing, and distribution channels in the global industry?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Circulating Tumor Cells Market Growth Fueled by Rising Cancer Incidence | Major Companies are QIAGEN, Fluxion Biosciences, Inc., Greiner Bio One International GmbH here

News-ID: 4145779 • Views:

More Releases from DataM Intelligence 4market Research LLP

Japan CAR-T Cell Therapy Market Forecast 2025-2033: Advancements in Allogeneic Therapies and Combination Treatments | Key Japanese Pharmaceutical Players Invest in Next-Gen CAR-T Cell Technologies
Japan CAR-T Cell Therapy Market Forecast 2025-2033: Advancements in Allogeneic T …
The Japan CAR-T cell therapies market reached US$ 346.00 million in 2024 and is expected to reach US$ 1,350.15 million by 2033, growing at a CAGR of 16.3% during the forecast period 2025-2033. The CAR-T Cell Therapies Market in Japan involves genetically engineered T-cells targeting cancer-specific antigens. Growth is driven by rising cancer incidence, advanced immunotherapies, and government support. Hospitals and specialized oncology centers are key end-users. Clinical trials focus on
Advanced Rocket and Missile Propulsion Systems Market to Reach USD 77.58 Billion by 2032 | Driving Innovations in Hypersonics and Green Propellants
Advanced Rocket and Missile Propulsion Systems Market to Reach USD 77.58 Billion …
Global Advanced Rocket and Missile Propulsion Systems Market size reached US$ 38.79 billion in 2024 and is expected to reach US$ 77.58 billion by 2032, growing with a CAGR of 9.05% during the forecast period 2025-2032. Advanced Rocket and Missile Propulsion Systems include solid, liquid, and hybrid engines used in defense, space, and aerospace applications. Growth is driven by defense modernization, space exploration, and missile defense initiatives. Technologies focus on high
Transparent Food Labeling Market to Reach USD 79.21 Billion by 2032, Growing at a CAGR of 7.87% | Increasing Demand for Organic, Non-GMO, and Allergen-Free Labels
Transparent Food Labeling Market to Reach USD 79.21 Billion by 2032, Growing at …
Global transparent food labeling market size reached US$ 43.21 billion in 2024 and is expected to reach US$ 79.21 billion by 2032, growing with a CAGR of 7.87% during the forecast period 2025-2032. Transparent Food Labeling involves providing clear, accurate information about ingredients, nutritional content, and allergens on packaged foods. Growth is driven by rising consumer awareness, health consciousness, and regulatory requirements. Labels often highlight organic, non-GMO, or allergen-free claims.
Regulatory Technology Market Outlook 2025-2032: Expansion in Cloud-Based and AI-Powered Compliance Tools | AI-Driven Analytics and Blockchain Enhance Efficiency in RegTech Compliance and Reporting
Regulatory Technology Market Outlook 2025-2032: Expansion in Cloud-Based and AI- …
Global RegTech Market reached US$ 20.04 billion in 2024 and is expected to reach US$ 33.36 billion by 2032, growing with a CAGR of 6.75% during the forecast period 2025-2032. The Regulatory Technology (RegTech) Market provides software and tools to ensure compliance, risk management, and reporting for financial institutions. Growth is driven by increasing regulations, fintech adoption, and fraud prevention needs. Solutions include AI-driven analytics, blockchain, and automated reporting systems.

All 5 Releases


More Releases for Circulating

Rising Cancer Incidence Drives Surge In Circulating Tumor Cells Market: Powering …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Circulating Tumor Cells Market Through 2025? In recent times, there has been a swift expansion in the size of the circulating tumor cells market. It is projected to enlarge from its 2024 value of $11.9 billion to reach $13.27 billion in 2025,
Circulating Tumour DNA Market Size Report 2034
On April 25, 2025, Exactitude Consultancy., Ltd. released a research report titled "Circulating Tumour DNA Market". This report covers the global Circulating Tumor DNA market sales, sales volume, price, market share, ranking of major companies, etc., and provides a detailed analysis by region, country, product type, and application. It also forecasts the market size of automotive kick sensors based on market patterns from 2020 to 2034 and future market trends.
Key Trend Reshaping the Circulating Fluid Bed Boilers Market in 2025: Strategic …
What combination of drivers is leading to accelerated growth in the circulating fluid bed boilers market? The circulating fluid bed boiler market is predicted to expand due to a surge in coal consumption. Coal, a black rock extracted from the earth, is used as fuel. These boilers are typically found in coal-fired power plants, where they create steam to run large turbines, and the mineral components of coal are converted into
Circulating Water Baths Market Size 2024 to 2031.
Market Overview and Report Coverage A circulating water bath is a laboratory device used to heat or cool samples in a controlled environment. These baths are essential equipment in various industries such as healthcare, pharmaceuticals, and research labs for conducting experiments that require precise temperature control. The circulating water baths market is expected to witness significant growth in the coming years, with a projected CAGR of 5.00% during the forecasted
Circulating Tumor Cells Market 2023 | Detailed Report
The Circulating Tumor Cells report compiles the market information depending upon market development and growth factors, optimizing the growth path. In addition, it highlights the strategies and market share of the leading vendors in the particular market. The report follows a robust research methodology model that helps to make informed decisions. It obtains both qualitative and quantitative market information supported by primary research. The Circulating Tumor Cells research report recognizes and
Global Circulating Cell-Free DNA Diagnostics Market
According to a new market research report published by Global Market Estimates, the Global Circulating Cell-Free DNA (ccfDNA) Diagnostics Market is projected to grow from USD 4.9 billion in 2022 to USD 13.1 billion in 2027 at a CAGR of 21.7% from 2022 to 2027. Hoffmann-La Roche, Natera Inc., Illumina Inc., Agena Bioscience, Paragon Genomics, Thermo Fisher Scientific, Bio-Rad Laboratories, Lucence Health, and Eurofins among others are some key players in